Two strategics and a private equity player are bidding for Unilabs, the Pan-European, Mid East and LaTam lab and imaging group. So who is likely to win?
The UK has just passed a new law that stands to shake up the procurement of healthcare services. The for-profit sector has hoped it could drive more patients to their businesses, especially against ballooning waiting lists and winter pressure, but experts tell HBI there's little chance it will increase outsourcing.
Global lab and imaging group Unilabs is in the second round of its sales process, HBI hears, with four bidders made up of private equity and strategic buyers.
Finland's largest for-profit healthcare operator by revenue Mehiläinen has made its first acquisition in Germany. The acquired hospital, Dalberg Klinik, is the ticket to further investments in the country's outpatient sector, HBI hears from Janne-Olli Järvenpää, Mehiläinen's CEO.
Spain will spend over €450m on the digitalisation of its primary care sector, building a new data network and AI as part of a new €1.5bn healthcare budget. The sector, however, says it is not enough.
Hospital group HCA Healthcare UK is taking on 30 nurse refugees from Lebanon to work in its UK hospitals. Its charity partner wants to roll out the scheme to other private hospitals.
There are two big deals in fertility this week, as global investment company KKR has acquired health, wellness and fitness group GeneraLife IVF (formerly Ginefiv) from Southern Europe focussed Investindustrial, and Mediclinic Middle East has acquired 100% of Bourn Hall Fertility Centre in the MENA region.
Romania's public hospitals are overrun with COVID patients. The 3,400+ beds owned by the private sector aren't being used for infected patients but instead as an 'overflow' for the otherwise ill. HBI speaks to the CEO of Regina Maria, who says visits to its ER are up 25% and looks at the results of rival Medlife, where revenue is up 57% in the first nine months.
The Finnish competition regulator has approved Mehiläinen's acquisition of Vetrea's residential care business, showing that the big groups can still push for greater market share.
The Chinese government has banned remote consultations without prior diagnosis and forbidden AI as a substitute for doctors in a major crackdown on the digital health sector. The new rules have left stocks reeling.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
